Fei Gao1, Yang-Kui Gu, Wei-Jun Fan, Liang Zhang, Jin-Hua Huang. 1. State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-Sen University, 615 East Dongfeng Road, Guangzhou, Guangdong Province, China.
Abstract
AIM: To assess the effects of combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol ablation (PEA) in patients with large hepatocellular carcinoma (HCC). METHODS: A total of 63 patients with unresectable large HCC were treated with TACE followed by PEA. The largest dimension of the tumors ranged from 5.3 cm to 17.8 cm. The survival rates, acute effects, toxicity and prognostic factors were analyzed. RESULTS: The cumulative survival rates at 1, 3 and 5 years were 59.4%, 28.4% and 15.8%, respectively (a median survival of 27.7 mo). Tumor area was reduced by more than 50% in 30 (47.6%) cases. In 56 cases with increased α-fetoprotein (AFP) values, AFP level was declined by more than 75%. The combined therapy was generally well tolerated. Only two patients died from variceal bleeding associated with the therapy. The Cox proportional hazards model showed that the number of tumors, the tumor margin and the ethanol dose were independent prognostic factors. CONCLUSION: The combined TACE and PEA therapy is a promising approach for unresectable large HCC.
AIM: To assess the effects of combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol ablation (PEA) in patients with large hepatocellular carcinoma (HCC). METHODS: A total of 63 patients with unresectable large HCC were treated with TACE followed by PEA. The largest dimension of the tumors ranged from 5.3 cm to 17.8 cm. The survival rates, acute effects, toxicity and prognostic factors were analyzed. RESULTS: The cumulative survival rates at 1, 3 and 5 years were 59.4%, 28.4% and 15.8%, respectively (a median survival of 27.7 mo). Tumor area was reduced by more than 50% in 30 (47.6%) cases. In 56 cases with increased α-fetoprotein (AFP) values, AFP level was declined by more than 75%. The combined therapy was generally well tolerated. Only two patients died from variceal bleeding associated with the therapy. The Cox proportional hazards model showed that the number of tumors, the tumor margin and the ethanol dose were independent prognostic factors. CONCLUSION: The combined TACE and PEA therapy is a promising approach for unresectable large HCC.
Authors: K Tanaka; S Nakamura; K Numata; M Kondo; K Morita; T Kitamura; S Saito; T Kiba; H Okazaki; H Sekihara Journal: Cancer Date: 1998-01-01 Impact factor: 6.860
Authors: H Ishii; S Okada; H Nose; T Okusaka; M Yoshimori; T Takayama; T Kosuge; S Yamasaki; M Sakamoto; S Hirohashi Journal: Cancer Date: 1996-05-01 Impact factor: 6.860
Authors: K Tanaka; S Nakamura; K Numata; H Okazaki; O Endo; S Inoue; Y Takamura; M Sugiyama; Y Ohaki Journal: Radiology Date: 1992-11 Impact factor: 11.105
Authors: R Yamada; K Kishi; M Sato; T Sonomura; N Nishida; K Tanaka; Y Shioyama; M Terada; M Kimura Journal: World J Surg Date: 1995 Nov-Dec Impact factor: 3.352
Authors: L Mondazzi; R Bottelli; G Brambilla; A Rampoldi; I Rezakovic; C Zavaglia; A Alberti; G Idèo Journal: Hepatology Date: 1994-05 Impact factor: 17.425
Authors: K Nishimine; H Uchida; N Matsuo; H Sakaguchi; S Hirohashi; Y Nishimura; Q Guo; H Ohishi; N Nagano; T Yoshioka Journal: Cancer Chemother Pharmacol Date: 1994 Impact factor: 3.333